Kimia Farma Persero Tbk (JK:KAEF) — Market Cap & Net Worth
Market Cap & Net Worth: Kimia Farma Persero Tbk (KAEF)
Kimia Farma Persero Tbk (JK:KAEF) has a market capitalization of $155.91 Million (Rp2.66 Trillion) as of May 2, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #17494 globally and #277 in its home market, demonstrating a -10.65% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Kimia Farma Persero Tbk's stock price Rp478.00 by its total outstanding shares 5566588406 (5.57 Billion). Analyse how efficiently does Kimia Farma Persero Tbk generate cash to see how efficiently the company converts income to cash.
Kimia Farma Persero Tbk Market Cap History: 2015 to 2026
Kimia Farma Persero Tbk's market capitalization history from 2015 to 2026. Data shows change from $274.09 Million to $155.91 Million (-5.52% CAGR).
Index Memberships
Kimia Farma Persero Tbk is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$540.85 Billion | 0.03% | #271 of 864 |
Weight: Kimia Farma Persero Tbk's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Kimia Farma Persero Tbk Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Kimia Farma Persero Tbk's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Kimia Farma Persero Tbk's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $274.09 Million | $4.86 Trillion | $248.85 Billion | 0.00x | 0.00x |
| 2016 | $872.23 Million | $5.81 Trillion | $267.41 Billion | 0.00x | 0.00x |
| 2017 | $859.75 Million | $6.13 Trillion | $326.79 Billion | 0.00x | 0.00x |
| 2018 | $834.42 Million | $7.45 Trillion | $415.90 Billion | 0.00x | 0.00x |
| 2019 | $403.06 Million | $9.40 Trillion | -$12.72 Billion | 0.00x | N/A |
| 2020 | $1.37 Billion | $10.01 Trillion | $17.64 Billion | 0.00x | 0.08x |
| 2021 | $783.93 Million | $12.86 Trillion | $302.27 Billion | 0.00x | 0.00x |
| 2022 | $353.91 Million | $9.23 Trillion | -$190.47 Billion | 0.00x | N/A |
| 2023 | $471.33 Million | $9.97 Trillion | -$1.49 Trillion | 0.00x | N/A |
| 2024 | $197.34 Million | $9.94 Trillion | -$842.27 Billion | 0.00x | N/A |
Competitor Companies of KAEF by Market Capitalization
Companies near Kimia Farma Persero Tbk in the global market cap rankings as of May 2, 2026.
Key companies related to Kimia Farma Persero Tbk by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #246 globally with a market cap of $99.71 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #441 globally with a market cap of $59.14 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #570 globally with a market cap of $45.94 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1111 globally with a market cap of $22.95 Billion USD ( AU$32.44 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #246 | McKesson Corporation | NYSE:MCK | $99.71 Billion | $814.02 |
| #441 | Cencora Inc. | NYSE:COR | $59.14 Billion | $304.00 |
| #570 | Cardinal Health Inc | NYSE:CAH | $45.94 Billion | $195.24 |
| #1111 | Sigma Healthcare Ltd | AU:SIG | $22.95 Billion | AU$2.81 |
Kimia Farma Persero Tbk Historical Marketcap From 2015 to 2026
Between 2015 and today, Kimia Farma Persero Tbk's market cap moved from $274.09 Million to $ 155.91 Million, with a yearly change of -5.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp155.91 Million | -7.18% |
| 2025 | Rp167.98 Million | -14.88% |
| 2024 | Rp197.34 Million | -58.13% |
| 2023 | Rp471.33 Million | +33.18% |
| 2022 | Rp353.91 Million | -54.86% |
| 2021 | Rp783.93 Million | -42.80% |
| 2020 | Rp1.37 Billion | +240.00% |
| 2019 | Rp403.06 Million | -51.70% |
| 2018 | Rp834.42 Million | -2.95% |
| 2017 | Rp859.75 Million | -1.43% |
| 2016 | Rp872.23 Million | +218.23% |
| 2015 | Rp274.09 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Kimia Farma Persero Tbk was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $155.91 Million USD |
| MoneyControl | $155.91 Million USD |
| MarketWatch | $155.91 Million USD |
| marketcap.company | $155.91 Million USD |
| Reuters | $155.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Kimia Farma Persero Tbk
PT Kimia Farma Tbk engages in the research, development, manufacture, and sale of pharmaceutical products in Indonesia and internationally. It offers generic drugs and ethical products; over-the-counter products and herbs; and cosmetic products. The company also provides integrated health clinic and medical laboratory services; operates a beauty clinic; and retails pharmaceutical products, as wel… Read more